vs
ICU MEDICAL INC（ICUI）与Simpson Manufacturing Co., Inc.（SSD）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Simpson Manufacturing Co., Inc.的1.0倍（$540.7M vs $539.3M），Simpson Manufacturing Co., Inc.净利率更高（10.4% vs -2.9%，领先13.3%），Simpson Manufacturing Co., Inc.同比增速更快（4.2% vs -14.1%），Simpson Manufacturing Co., Inc.自由现金流更多（$119.0M vs $36.0M），过去两年Simpson Manufacturing Co., Inc.的营收复合增速更高（0.8% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
辛普森制造是美国领先的建筑材料生产企业，主营面向新建建筑及改造翻新项目的结构连接件、紧固件、锚固件等专业产品，在建筑配套材料领域具备深厚的技术积累与较高的市场认可度。
ICUI vs SSD — 直观对比
营收规模更大
ICUI
是对方的1.0倍
$539.3M
营收增速更快
SSD
高出18.4%
-14.1%
净利率更高
SSD
高出13.3%
-2.9%
自由现金流更多
SSD
多$83.0M
$36.0M
两年增速更快
SSD
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $539.3M |
| 净利润 | $-15.7M | $56.2M |
| 毛利率 | 37.5% | 43.4% |
| 营业利润率 | 1.0% | 13.9% |
| 净利率 | -2.9% | 10.4% |
| 营收同比 | -14.1% | 4.2% |
| 净利润同比 | 34.0% | 1.4% |
| 每股收益（稀释后） | $-0.63 | $1.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUISSD
| Q4 25 | $540.7M | $539.3M | ||
| Q3 25 | $537.0M | $623.5M | ||
| Q2 25 | $548.9M | $631.1M | ||
| Q1 25 | $604.7M | $538.9M | ||
| Q4 24 | $629.8M | $517.4M | ||
| Q3 24 | $589.1M | $587.2M | ||
| Q2 24 | $596.5M | $597.0M | ||
| Q1 24 | $566.7M | $530.6M |
净利润ICUISSD
| Q4 25 | $-15.7M | $56.2M | ||
| Q3 25 | $-3.4M | $107.4M | ||
| Q2 25 | $35.3M | $103.5M | ||
| Q1 25 | $-15.5M | $77.9M | ||
| Q4 24 | $-23.8M | $55.4M | ||
| Q3 24 | $-33.0M | $93.5M | ||
| Q2 24 | $-21.4M | $97.8M | ||
| Q1 24 | $-39.5M | $75.4M |
毛利率ICUISSD
| Q4 25 | 37.5% | 43.4% | ||
| Q3 25 | 37.4% | 46.4% | ||
| Q2 25 | 37.9% | 46.7% | ||
| Q1 25 | 34.7% | 46.8% | ||
| Q4 24 | 36.1% | 44.0% | ||
| Q3 24 | 34.8% | 46.8% | ||
| Q2 24 | 34.8% | 46.7% | ||
| Q1 24 | 32.7% | 46.1% |
营业利润率ICUISSD
| Q4 25 | 1.0% | 13.9% | ||
| Q3 25 | 2.6% | 22.6% | ||
| Q2 25 | 1.9% | 22.2% | ||
| Q1 25 | 2.1% | 19.0% | ||
| Q4 24 | 6.0% | 14.8% | ||
| Q3 24 | 1.4% | 21.3% | ||
| Q2 24 | 1.3% | 22.1% | ||
| Q1 24 | -1.9% | 18.1% |
净利率ICUISSD
| Q4 25 | -2.9% | 10.4% | ||
| Q3 25 | -0.6% | 17.2% | ||
| Q2 25 | 6.4% | 16.4% | ||
| Q1 25 | -2.6% | 14.5% | ||
| Q4 24 | -3.8% | 10.7% | ||
| Q3 24 | -5.6% | 15.9% | ||
| Q2 24 | -3.6% | 16.4% | ||
| Q1 24 | -7.0% | 14.2% |
每股收益（稀释后）ICUISSD
| Q4 25 | $-0.63 | $1.34 | ||
| Q3 25 | $-0.14 | $2.58 | ||
| Q2 25 | $1.43 | $2.47 | ||
| Q1 25 | $-0.63 | $1.85 | ||
| Q4 24 | $-0.97 | $1.31 | ||
| Q3 24 | $-1.35 | $2.21 | ||
| Q2 24 | $-0.88 | $2.31 | ||
| Q1 24 | $-1.63 | $1.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $384.1M |
| 总债务越低越好 | — | $300.0M |
| 股东权益账面价值 | $2.1B | $2.0B |
| 总资产 | $4.1B | $3.1B |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资ICUISSD
| Q4 25 | — | $384.1M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $190.4M | ||
| Q1 25 | — | $150.3M | ||
| Q4 24 | $308.6M | $239.4M | ||
| Q3 24 | $312.5M | $339.4M | ||
| Q2 24 | $302.6M | $354.9M | ||
| Q1 24 | $251.4M | $369.1M |
总债务ICUISSD
| Q4 25 | — | $300.0M | ||
| Q3 25 | — | $371.3M | ||
| Q2 25 | — | $376.9M | ||
| Q1 25 | — | $382.5M | ||
| Q4 24 | — | $388.1M | ||
| Q3 24 | — | $393.8M | ||
| Q2 24 | — | $399.4M | ||
| Q1 24 | — | $405.0M |
股东权益ICUISSD
| Q4 25 | $2.1B | $2.0B | ||
| Q3 25 | $2.1B | $2.0B | ||
| Q2 25 | $2.1B | $1.9B | ||
| Q1 25 | $2.0B | $1.9B | ||
| Q4 24 | $2.0B | $1.8B | ||
| Q3 24 | $2.0B | $1.9B | ||
| Q2 24 | $2.0B | $1.8B | ||
| Q1 24 | $2.1B | $1.7B |
总资产ICUISSD
| Q4 25 | $4.1B | $3.1B | ||
| Q3 25 | $4.1B | $3.0B | ||
| Q2 25 | $4.1B | $3.0B | ||
| Q1 25 | $4.2B | $2.8B | ||
| Q4 24 | $4.2B | $2.7B | ||
| Q3 24 | $4.3B | $2.9B | ||
| Q2 24 | $4.3B | $2.8B | ||
| Q1 24 | $4.3B | $2.7B |
负债/权益比ICUISSD
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $155.7M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $119.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 22.1% |
| 资本支出强度资本支出/营收 | 4.6% | 6.8% |
| 现金转化率经营现金流/净利润 | — | 2.77× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $297.6M |
8季度趋势，按日历期对齐
经营现金流ICUISSD
| Q4 25 | $60.6M | $155.7M | ||
| Q3 25 | $56.7M | $170.2M | ||
| Q2 25 | $11.2M | $125.2M | ||
| Q1 25 | $51.3M | $7.6M | ||
| Q4 24 | $40.2M | $115.8M | ||
| Q3 24 | $36.1M | $103.3M | ||
| Q2 24 | $82.0M | $111.1M | ||
| Q1 24 | $45.8M | $7.9M |
自由现金流ICUISSD
| Q4 25 | $36.0M | $119.0M | ||
| Q3 25 | $27.6M | $133.9M | ||
| Q2 25 | $-8.5M | $87.3M | ||
| Q1 25 | $36.7M | $-42.6M | ||
| Q4 24 | $16.1M | $60.3M | ||
| Q3 24 | $16.2M | $58.1M | ||
| Q2 24 | $62.5M | $70.9M | ||
| Q1 24 | $29.9M | $-31.5M |
自由现金流率ICUISSD
| Q4 25 | 6.6% | 22.1% | ||
| Q3 25 | 5.1% | 21.5% | ||
| Q2 25 | -1.5% | 13.8% | ||
| Q1 25 | 6.1% | -7.9% | ||
| Q4 24 | 2.6% | 11.7% | ||
| Q3 24 | 2.7% | 9.9% | ||
| Q2 24 | 10.5% | 11.9% | ||
| Q1 24 | 5.3% | -5.9% |
资本支出强度ICUISSD
| Q4 25 | 4.6% | 6.8% | ||
| Q3 25 | 5.4% | 5.8% | ||
| Q2 25 | 3.6% | 6.0% | ||
| Q1 25 | 2.4% | 9.3% | ||
| Q4 24 | 3.8% | 10.7% | ||
| Q3 24 | 3.4% | 7.7% | ||
| Q2 24 | 3.3% | 6.7% | ||
| Q1 24 | 2.8% | 7.4% |
现金转化率ICUISSD
| Q4 25 | — | 2.77× | ||
| Q3 25 | — | 1.58× | ||
| Q2 25 | 0.32× | 1.21× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 2.09× | ||
| Q3 24 | — | 1.10× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SSD
| Wood Construction | $352.0M | 65% |
| Other | $122.4M | 23% |
| Concrete Construction | $64.6M | 12% |
| Other Products | $318.0K | 0% |
